Philipp von Rosenstiel

Philipp von Rosenstiel is an accomplished medical professional with extensive experience in the field of neuroscience, particularly in Alzheimer’s and dementia research. Currently serving as Vice President of Global Clinical Sciences at Takeda, Philipp has previously held significant roles at Biogen as Executive Medical Director and Senior Medical Director, as well as Global Program Medical Director at Novartis. Philipp has also contributed to the academic field as a lecturer in the MSc in Cerebrovascular Medicine at Charité and has served as Senior Clinical Program Director at UCB. With a Doctor of Medicine degree from Ludwig-Maximilians-Universität München and a doctorate in Neurobiology from the Max-Planck-Institute for Psychiatry, Philipp combines strong clinical expertise with a solid educational background.